Valeo Pharma Inc.
VPHIF
$0.0469
-$0.0471-50.11%
OTC PK
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.71% | -20.37% | -9.81% | 2.73% | -4.63% |
| Total Depreciation and Amortization | -3.20% | 1.23% | -4.87% | 73.67% | 137.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -66.65% | -- |
| Total Other Non-Cash Items | 397.06% | 14.42% | 39.96% | -65.75% | -24.25% |
| Change in Net Operating Assets | 29.23% | -51.64% | 200.10% | 153.16% | 51.53% |
| Cash from Operations | 134.90% | -529.15% | 114.68% | 76.45% | 43.34% |
| Capital Expenditure | -- | 83.14% | 50.60% | 32.28% | -78.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 466.37% | -198.02% | -- |
| Cash from Investing | -- | 642.00% | 227.64% | -199.43% | 99.07% |
| Total Debt Issued | -- | -- | -- | 104.97% | -96.58% |
| Total Debt Repaid | -328.07% | -290.24% | -322.00% | -119.87% | 85.19% |
| Issuance of Common Stock | -- | -- | -- | 391,900.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.57% | -- |
| Cash from Financing | -119.44% | -308.85% | 1,018.33% | 12,181.17% | -96.70% |
| Foreign Exchange rate Adjustments | 114.45% | 29.84% | -1.59% | -62.61% | -30.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.74% | -222.16% | 118.01% | 57.32% | -101.47% |